As Low As $0
Out of Pocket
co-pay-caret
XEOMIN - Clinical Trials for Upper Limb Spasticity

Adults With Upper Limb Spasticity

Disease
Overview
Clinical
Trial
Efficacy Safety Dosing

Pivotal Trial Design

Randomized, Placebo-Controlled Trial of XEOMIN for Upper Limb Spasticity (PURE)1,2

Primary endpoints (Main Phase):

Endpoints (OLEX Phase):

Pivotal trial design

Pivotal safety and efficacy trial

References

  1. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2019.
  2. Elovic EP, Munin MC, Kanovsky P, Hanschmann A, Hiersemenzel R, Marciniak C. Randomized, placebo-controlled trial of incobotulinumtoxinA for upper limb post-stroke spasticity. Muscle Nerve. 2016;53(3):415-421.